Company intelligence / Profile preview

Qualilife Pharmaceuticals

Ownership: Private
Development stage: Other

Overview

Qualilife Pharmaceuticals developed Zestra, a topical formulation evaluated in a Phase 3 randomized, placebo-controlled clinical trial for women with mixed desire/interest/arousal/orgasm disorders. The study was completed and focused on efficacy and safety under home usage conditions. No additional pipeline programs are listed as active or in development as of early 2025.

Therapeutic areas: Women's Health
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Qualilife Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qualilife Pharmaceuticals.

Explore the full profile